Tenders Are Invited For Conclusion Of Non-Exclusive Discount Agreements According To 130 A Paragraph 8 Sgb ...
Tender Notice
TenderID
65189902
Tender Brief
Tenders Are Invited For Conclusion Of Non-Exclusive Discount Agreements According To 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Ramipril + Piretanid
Conclusion Of Non-Exclusive Discount Agreements According To 130 A Paragraph 8 Sgb V For Drugs With The Active Ingredient Ramipril + Piretanid. 130A Paragraph 8 Sgb V Enables The Health Insurance Companies (Kk) And Pharmaceutical Companies To Conclude Framework Discount Agreements For The Drugs To Be Dispensed At The Expense Of The Statutory Kk. The Gwq Acts As A Company For Efficiency And Quality At Kk According To 130A Paragraph 8 Sentence 5 Sgbv For Its Shareholders And Customer Funds. With Regard To The Relevant Legal Regulations For Awarding Public Contracts, A Regular Process Of Active Ingredient-Related, Formal Award Procedures Takes Place According To The Regulations Of Part 4 Of The Gwb By Gwq Serviceplus Ag. By The Time New Drug Discount Agreements Come Into Force, The Gwq Would Like To Conclude Drug Discount Agreements With All Interested Pharmaceutical Companies. The Start Of The Contract Is July 1St, 2023
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 65189902
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
